236 related articles for article (PubMed ID: 16804722)
21. A panel of immunohistochemical stains, including carcinoembryonic antigen, vimentin, and estrogen receptor, aids the distinction between primary endometrial and endocervical adenocarcinomas.
McCluggage WG; Sumathi VP; McBride HA; Patterson A
Int J Gynecol Pathol; 2002 Jan; 21(1):11-5. PubMed ID: 11781517
[TBL] [Abstract][Full Text] [Related]
22. [Expression of fascin and CK14 in different histological types of cancer and its differential diagnostic significance].
Xue LY; Zou SM; Zheng S; Xie YQ; Wen P; Liu XY; Lin DM; Lü N
Zhonghua Zhong Liu Za Zhi; 2010 Nov; 32(11):838-44. PubMed ID: 21223690
[TBL] [Abstract][Full Text] [Related]
23. Sperm protein 17 is highly expressed in endometrial and cervical cancers.
Li FQ; Liu Q; Han YL; Wu B; Yin HL
BMC Cancer; 2010 Aug; 10():429. PubMed ID: 20712874
[TBL] [Abstract][Full Text] [Related]
24. Expression of transforming growth factor-alpha in the normal cervix and in benign and malignant lesions of the uterine cervix.
Konishi I; Ishikawa Y; Wang SY; Wang DP; Koshiyama M; Mandai M; Komatsu T; Yamamoto S; Mori T
Br J Obstet Gynaecol; 1994 Apr; 101(4):325-9. PubMed ID: 8199079
[TBL] [Abstract][Full Text] [Related]
25. Cervicovaginal cytology in uterine adenocarcinoma and adenosquamous carcinoma. Comparison of cytologic and histologic findings.
Costa MJ; Kenny MB; Naib ZM
Acta Cytol; 1991; 35(1):127-34. PubMed ID: 1994621
[TBL] [Abstract][Full Text] [Related]
26. Mammaglobin expression in gynecologic adenocarcinomas.
Hagemann IS; Pfeifer JD; Cao D
Hum Pathol; 2013 Apr; 44(4):628-35. PubMed ID: 23084633
[TBL] [Abstract][Full Text] [Related]
27. [Expression of annexin I in different histological types of carcinomas].
Xue LY; Teng LH; Zou SM; Ren LQ; Zheng S; Luo W; Bi R; Lü N
Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):444-8. PubMed ID: 17974280
[TBL] [Abstract][Full Text] [Related]
28. Histopathology of cervical precursor lesions and cancer.
Lax S
Acta Dermatovenerol Alp Pannonica Adriat; 2011 Sep; 20(3):125-33. PubMed ID: 22131112
[TBL] [Abstract][Full Text] [Related]
29. The clinicopathologic significance of laminin-5 gamma2 chain expression in cervical squamous carcinoma and adenocarcinoma.
Andersson S; Hellström AC; Angström T; Stendahl U; Auer G; Wallin KL
Int J Gynecol Cancer; 2005; 15(6):1065-72. PubMed ID: 16343183
[TBL] [Abstract][Full Text] [Related]
30. Loss of gamma-Catenin expression in squamous differentiation in endometrial carcinomas.
Ashihara K; Saito T; Mizumoto H; Adachi K; Tanaka R; Nishimura M; Ito E; Kudo R
Int J Gynecol Pathol; 2002 Jul; 21(3):246-54. PubMed ID: 12068170
[TBL] [Abstract][Full Text] [Related]
31. In situ adenocarcinoma and squamous carcinoma of uterine cervix. Pathological and immunohistochemical analysis with cytokeratin 13.
Raspollini MR; Fambrini M; Marchionni M; Baroni G; Taddei GL
Eur J Obstet Gynecol Reprod Biol; 2007 Oct; 134(2):249-53. PubMed ID: 16949723
[TBL] [Abstract][Full Text] [Related]
32. Localization of carcinoembryonic antigen in uterine cervical neoplasia.
Agarwal S; Sharma S
Indian J Med Res; 1990 Dec; 92():452-5. PubMed ID: 2079363
[TBL] [Abstract][Full Text] [Related]
33. CD109 expression in squamous cell carcinoma of the uterine cervix.
Zhang JM; Hashimoto M; Kawai K; Murakumo Y; Sato T; Ichihara M; Nakamura S; Takahashi M
Pathol Int; 2005 Apr; 55(4):165-9. PubMed ID: 15826242
[TBL] [Abstract][Full Text] [Related]
34. [Morphology, immunohistochemistry and differential diagnosis of 70 cases of adenocarcinoma of uterine cervix].
Huang J
Zhonghua Bing Li Xue Za Zhi; 1993 Apr; 22(2):98-100. PubMed ID: 8403106
[TBL] [Abstract][Full Text] [Related]
35. Cervical Carcinomas With Neuroendocrine Differentiation: A Report of 28 Cases With Immunohistochemical Analysis and Molecular Genetic Evidence of Common Clonal Origin With Coexisting Squamous and Adenocarcinomas.
Emerson RE; Michael H; Wang M; Zhang S; Roth LM; Cheng L
Int J Gynecol Pathol; 2016 Jul; 35(4):372-84. PubMed ID: 26630233
[TBL] [Abstract][Full Text] [Related]
36. P16INK4a expression in undifferentiated carcinoma of the uterus does not exclude its endometrial origin.
Saad RS; Mashhour M; Noftech-Mozes S; Ismiil N; Dubé V; Ghorab Z; Faragalla H; Khalifa MA
Int J Gynecol Pathol; 2012 Jan; 31(1):57-65. PubMed ID: 22123724
[TBL] [Abstract][Full Text] [Related]
37. The possible role of p53 and bcl-2 expression in cervical carcinomas and their premalignant lesions.
Dimitrakakis C; Kymionis G; Diakomanolis E; Papaspyrou I; Rodolakis A; Arzimanoglou I; Leandros E; Michalas S
Gynecol Oncol; 2000 Apr; 77(1):129-36. PubMed ID: 10739702
[TBL] [Abstract][Full Text] [Related]
38. Uterine cervical carcinomas associated with lobular endocervical glandular hyperplasia.
Tsuji T; Togami S; Nomoto M; Higashi M; Fukukura Y; Kamio M; Yonezawa S; Douchi T
Histopathology; 2011 Jul; 59(1):55-62. PubMed ID: 21771026
[TBL] [Abstract][Full Text] [Related]
39. Identification of a basal/reserve cell immunophenotype in benign and neoplastic endometrium: a study with the p53 homologue p63.
O'Connell JT; Mutter GL; Cviko A; Nucci M; Quade BJ; Kozakewich HP; Neffen E; Sun D; Yang A; McKeon FD; Crum CP
Gynecol Oncol; 2001 Jan; 80(1):30-6. PubMed ID: 11136566
[TBL] [Abstract][Full Text] [Related]
40. Utility of p16 expression for distinction of uterine serous carcinomas from endometrial endometrioid and endocervical adenocarcinomas: immunohistochemical analysis of 201 cases.
Yemelyanova A; Ji H; Shih IeM; Wang TL; Wu LS; Ronnett BM
Am J Surg Pathol; 2009 Oct; 33(10):1504-14. PubMed ID: 19623034
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
